Trials / Completed
CompletedNCT04560647
Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Wright State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to understand the role of a specific protein, tumor protein p63 in the skin disease psoriasis. This study is to further understand how psoriasis lesions happens. An understanding of key mediators that lead to psoriasis might aid in the discovery of more effective treatments for this skin disorder. This is not an intervention study. The study is looking to obtain currently untreated plaque psoriasis biopsies and also biopsies from non psoriasis patients. Psoriasis and medical history will be collected then skin biopsies will be obtained from the subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention - Psoriasis Subject | Not currently treated plaque psoriasis patients |
| OTHER | No intervention - Control Subject | Control subjects without plaque psoriasis and no family history of psoriasis |
Timeline
- Start date
- 2020-12-03
- Primary completion
- 2023-04-14
- Completion
- 2023-04-14
- First posted
- 2020-09-23
- Last updated
- 2023-04-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04560647. Inclusion in this directory is not an endorsement.